172 related articles for article (PubMed ID: 34626801)
1. Expression and purification of a cleavable recombinant fortilin from Escherichia coli for structure activity studies.
Cantrell MS; Wall JD; Pu X; Turner M; Woodbury L; Fujise K; McDougal OM; Warner LR
Protein Expr Purif; 2022 Jan; 189():105989. PubMed ID: 34626801
[TBL] [Abstract][Full Text] [Related]
2. High-level expression of soluble recombinant proteins in Escherichia coli using an HE-maltotriose-binding protein fusion tag.
Han Y; Guo W; Su B; Guo Y; Wang J; Chu B; Yang G
Protein Expr Purif; 2018 Feb; 142():25-31. PubMed ID: 28963004
[TBL] [Abstract][Full Text] [Related]
3. Expression and Purification of Recombinant Proteins in Escherichia coli with a His
Raran-Kurussi S; Waugh DS
Methods Mol Biol; 2017; 1607():1-15. PubMed ID: 28573567
[TBL] [Abstract][Full Text] [Related]
4. A new fusion protein platform for quantitatively measuring activity of multiple proteases.
Zhou C; Yan Y; Fang J; Cheng B; Fan J
Microb Cell Fact; 2014 Mar; 13(1):44. PubMed ID: 24649897
[TBL] [Abstract][Full Text] [Related]
5. Systematic analysis of the expression, solubility and purification of a passenger protein in fusion with different tags.
Bernier SC; Cantin L; Salesse C
Protein Expr Purif; 2018 Dec; 152():92-106. PubMed ID: 30036588
[TBL] [Abstract][Full Text] [Related]
6. Affinity Tags for Protein Purification.
Mishra V
Curr Protein Pept Sci; 2020; 21(8):821-830. PubMed ID: 32504500
[TBL] [Abstract][Full Text] [Related]
7. A comparison between MBP- and NT* as N-terminal fusion partner for recombinant protein production in E. coli.
Raran-Kurussi S; Sharwanlal SB; Balasubramanian D; Mote KR
Protein Expr Purif; 2022 Jan; 189():105991. PubMed ID: 34628000
[TBL] [Abstract][Full Text] [Related]
8. Removal of Affinity Tags with TEV Protease.
Raran-Kurussi S; Cherry S; Zhang D; Waugh DS
Methods Mol Biol; 2017; 1586():221-230. PubMed ID: 28470608
[TBL] [Abstract][Full Text] [Related]
9. Positional effects of fusion partners on the yield and solubility of MBP fusion proteins.
Raran-Kurussi S; Keefe K; Waugh DS
Protein Expr Purif; 2015 Jun; 110():159-64. PubMed ID: 25782741
[TBL] [Abstract][Full Text] [Related]
10. A dual protease approach for expression and affinity purification of recombinant proteins.
Raran-Kurussi S; Waugh DS
Anal Biochem; 2016 Jul; 504():30-7. PubMed ID: 27105777
[TBL] [Abstract][Full Text] [Related]
11. In vivo and in vitro characterization of TEV protease mutants.
Wei L; Cai X; Qi Z; Rong L; Cheng B; Fan J
Protein Expr Purif; 2012 Jun; 83(2):157-63. PubMed ID: 22484199
[TBL] [Abstract][Full Text] [Related]
12. High yield purification of nanobodies from the periplasm of E. coli as fusions with the maltose binding protein.
Salema V; Fernández LÁ
Protein Expr Purif; 2013 Sep; 91(1):42-8. PubMed ID: 23856605
[TBL] [Abstract][Full Text] [Related]
13. A new tagged-TEV protease: construction, optimisation of production, purification and test activity.
Miladi B; Bouallagui H; Dridi C; El Marjou A; Boeuf G; Di Martino P; Dufour F; Elm'Selmi A
Protein Expr Purif; 2011 Jan; 75(1):75-82. PubMed ID: 20817099
[TBL] [Abstract][Full Text] [Related]
14. Use of Recombinant Fusion Proteins in a Fluorescent Protease Assay Platform and Their In-gel Renaturation.
Bozóki B; Mótyán JA; Miczi M; Gazda LD; Tőzsér J
J Vis Exp; 2019 Jan; (143):. PubMed ID: 30735187
[TBL] [Abstract][Full Text] [Related]
15. A family of E. coli expression vectors for laboratory scale and high throughput soluble protein production.
Cabrita LD; Dai W; Bottomley SP
BMC Biotechnol; 2006 Mar; 6():12. PubMed ID: 16509985
[TBL] [Abstract][Full Text] [Related]
16. Prokaryotic soluble overexpression and purification of bioactive human growth hormone by fusion to thioredoxin, maltose binding protein, and protein disulfide isomerase.
Nguyen MT; Koo BK; Thi Vu TT; Song JA; Chong SH; Jeong B; Ryu HB; Moh SH; Choe H
PLoS One; 2014; 9(3):e89038. PubMed ID: 24614134
[TBL] [Abstract][Full Text] [Related]
17. Soluble overexpression and purification of bioactive human CCL2 in E. coli by maltose-binding protein.
Vu TT; Koo BK; Song JA; Chong SH; Park CR; Nguyen MT; Jeong B; Ryu HB; Seong JY; Jang YJ; Robinson RC; Choe H
Mol Biol Rep; 2015 Mar; 42(3):651-63. PubMed ID: 25391768
[TBL] [Abstract][Full Text] [Related]
18. Identification of a second binding site on the TRIM25 B30.2 domain.
D'Cruz AA; Kershaw NJ; Hayman TJ; Linossi EM; Chiang JJ; Wang MK; Dagley LF; Kolesnik TB; Zhang JG; Masters SL; Griffin MDW; Gack MU; Murphy JM; Nicola NA; Babon JJ; Nicholson SE
Biochem J; 2018 Jan; 475(2):429-440. PubMed ID: 29259080
[TBL] [Abstract][Full Text] [Related]
19. Grb7 protein RA domain oligomerization.
Godamudunage MP; Foster A; Warren D; Lyons BA
J Mol Recognit; 2017 Aug; 30(8):. PubMed ID: 28295715
[TBL] [Abstract][Full Text] [Related]
20. A recombinant fusion protein-based, fluorescent protease assay for high throughput-compatible substrate screening.
Bozóki B; Gazda L; Tóth F; Miczi M; Mótyán JA; Tőzsér J
Anal Biochem; 2018 Jan; 540-541():52-63. PubMed ID: 29122614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
